After days 9-10, incision lines can typically be well-covered with makeup and swelling and bruising is minimal
Clinical and genetic predictors of glycemic control and weight loss response to liraglutide in patients with type 2 diabetes
The immunomodulatory effects of prebiotics and synbiotics supplemented in ovo have been reported
OSA patients who received tirzepatide initiated CPAP therapy about 83% less often than those who did not receive the drug
Techniques for Achieving a Deep Latch If you notice any of the above signs that your babys latch may be suboptimal, try out the below tips to help you achieve a more comfortable and effective latch: Dont be scared to try again: If you latch your baby and feel sore, or notice that the latch is suboptimal, you dont need to push through
peaks during dose escalation, typically mild-moderate Diarrhea -- 10-20%, usually transient Constipation -- 8-15% Vomiting -- 5-15%, more frequent at higher doses Injection site reactions -- 5-10%, mild erythema and pruritus Decreased appetite -- 5-12%, related to mechanism of action Pancreatitis -- rare but monitored (as with all GLP-1/amylin agents) Gallbladder events -- cholelithiasis reported, consistent with rapid weight loss Trial data describes dose titration as central to tolerability -- the 16-week escalation protocol substantially reduced GI adverse events